Treatment for cocaine dependence
A PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED, TRIAL OF NS2359 FOR THE TREATMENT OF COCAINE DEPENDENCE If you suffer from cocaine dependence, a new clinical research study is available for you. The purpose of this research study is to test whether the drug, NS2359, is useful and safe for treating cocaine dependence.
Baclofen Effects in Cigarette Smokers
The purpose of our research is to study a medication that may help you quit smoking. We also want to learn more about how this medication impacts your response to smoking cues, or reminders in your environment that may cause you to crave cigarettes.
A Phase II Randomized Double-Blind Trial of Varenicline for the Treatment of Cocaine Dependence
This is a double-blind placebo-controlled clinical trial (n = 200) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance. Participants will be randomized (1:1) to receive varenicline (1.0 mg BID) for 12 weeks. Primary outcome measures include biochemically verified cocaine and nicotine use.
Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT® (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder
Alternating phone and in-clinic visits for medical management (MM), laboratory tests, and physical exams, to assess drug compliance, to complete additional questionnaires, and to provide counseling (via “Take Control” videos) over 29 weeks.